SCHEMBL2069759

SCHEMBL2069759

COc1ccccc1SC(C)[C@H](C)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
POLB P06746 3/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
TSHR P16473 2/20 0.39
HTT P42858 3/20 0.39
MAPT P10636 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2069251 1.00 KMT2A (0.50) KMT2AMTNR1AMTNR1BPOLBCA12
SCHEMBL28338828 0.81 KMT2A (0.50) KMT2AMTNR1AMTNR1BPOLBCA12
SCHEMBL6961103 0.81 KMT2A (0.50) KMT2AMTNR1AMTNR1BPOLBCA12
SCHEMBL5962399 0.75 CA1 (0.50) KMT2AMTNR1AMTNR1BPOLBCA12
SCHEMBL4266898 0.74 PPARG (0.52) KMT2AMTNR1AMTNR1BPOLBSMN1; SMN2
SCHEMBL8327013 0.73 MTNR1A (0.48) KMT2AMTNR1AMTNR1BPOLBCA12
SCHEMBL2069117 0.73 MTNR1A (0.51) KMT2AMTNR1AMTNR1BPOLBCA12
SCHEMBL7617760 0.73 POLB (0.47) KMT2AMTNR1AMTNR1BPOLBSMN1; SMN2
SCHEMBL2069498 0.73 MTNR1A (0.51) KMT2AMTNR1AMTNR1BPOLBCA12
SCHEMBL22035767 0.73 KMT2A (0.56) KMT2APOLBCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902381-B2 Synthesising method and benzoxathiepine intermediates PIERRE FABRE MEDICAMENT (FR) 2011-03-08 US disclosed